XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock-based compensation | 6 Months Ended
--- | ---
Apr. 30, 2022
Share-based Payment Arrangement [Abstract] |
Stock-based compensation | Stock-based compensation During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the 2021 Plan) as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the 2012 Plan). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that remained available to be granted under the 2012 Plan. As of April 30, 2022, a total of 2,126 common shares were available to be granted under the 2021 Plan. Stock Options Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25% per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $2,391 and $4,163 for the three and six months ended April 30, 2022, respectively compared to $1,565 and $3,801 for the three and six months ended April 30, 2021, respectively. The following table summarizes activity related to stock options for the six months ended April 30, 2022:
|  | Number of Options |  | Weighted- Average Exercise Price Per Share |  | Aggregate Intrinsic Value |  | Weighted Average Remaining Term
Outstanding at October 31, 2021 |  | 1,235 |  | $ | 130.93 |  |  |  |  |
Granted |  | 83 |  | 267.51 |  |  |  |  |
Exercised |  | (68) |  | 115.99 |  |  |  |  |
Forfeited or expired |  | (14) |  | 204.77 |  |  |  |  |
Outstanding at April 30, 2022 |  | 1,236 |  | $ | 140.12 |  |  | $ | 97,385 |  |  | 5.8 years
Expected to vest |  | 380 |  | $ | 185.05 |  |  | $ | 15,565 |  |  | 7.5 years
Exercisable at April 30, 2022 |  | 854 |  | $ | 119.99 |  |  | $ | 81,711 |  |  | 5.0 years
As of April 30, 2022, there was $9,848 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.1 years. The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Six Months Ended | April 30, 2022 |  | April 30, 2021
Expected volatility | 30.6% | - | 30.8% |  | 30.8% | - | 32.6%
Expected dividend yield | 0.76% | - | 0.76% |  | 0.83% | - | 0.85%
Risk-free interest rate | 1.36% | - | 1.47% |  | 0.43% | - | 0.77%
Expected life of the option (in years) | 5.3 | - | 6.2 |  | 5.3 | - | 6.2
The weighted-average expected volatility used to value the 2022 and 2021 options was 30.6% and 31.0%, respectively. Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued. The weighted average grant date fair value of stock options granted during the six months ended April 30, 2022 and 2021 was $79.03 and $56.02, respectively. The total intrinsic value of options exercised during the three months ended April 30, 2022 and 2021 was $2,405 and $12,166, respectively. The total intrinsic value of options exercised during the six months ended April 30, 2022 and 2021 was $9,366 and $17,601, respectively. Cash received from the exercise of stock options for the six months ended April 30, 2022 and 2021 was $7,798 and $18,783, respectively. Restricted Shares and Restricted Share Units We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. We may also grant continuation awards in the form of restricted share units with cliff vesting and a performance measure that must be achieved for the restricted share units to vest. For employee recipients, in the event of termination of employment due to early retirement with the consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units. For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units. As shares or units are issued, deferred stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period. The following table summarizes activity related to restricted shares during the six months ended April 30, 2022:
|  | Number of Shares |  | Weighted-Average Grant Date Fair Value
Restricted shares at October 31, 2021 |  | 19 |  |  | $ | 157.36 |
Vested |  | (10) |  |  | 146.50
Restricted shares at April 30, 2022 |  | 9 |  |  | $ | 171.11 |
As of April 30, 2022, there was $804 of unrecognized compensation cost related to restricted shares. The cost is expected to be amortized over a weighted average period of 0.5 years. The amount charged to expense related to restricted shares during the three months ended April 30, 2022 and 2021 was $299 and $501, respectively, which included common share dividends of $5 and $13, respectively. For the six months ended April 30, 2022 and 2021, the amounts charged to expense related to restricted shares were $613 and $1,465, respectively, which included common share dividends of $10 and $31, respectively. The following table summarizes activity related to restricted share units during the six months ended April 30, 2022:
|  | Number of Units |  | Weighted-Average Grant Date Fair Value
Restricted share units at October 31, 2021 |  | 67 |  |  | $ | 202.81 |
Granted |  | 41 |  |  | 263.75
Forfeited |  | (8) |  |  | 221.84
Vested |  | (15) |  |  | 201.79
Restricted share units at April 30, 2022 |  | 85 |  |  | $ | 230.34 |
As of April 30, 2022, there was $13,426 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 1.0 year. The amount charged to expense related to restricted share units during each of the three months ended April 30, 2022 and 2021 was $1,819 and $2,192, respectively, compared to $4,092 and $4,284 for the six months ended April 30, 2022 and 2021, respectively. Performance Share Incentive Awards Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved. The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value which is principally driven by the stock price on the date of grant or a Monte Carlo valuation for awards with market conditions. The per share values were $260.60 and $273.50 for 2022 and $202.50 for 2021. The amount charged to expense for the three months ended April 30, 2022 was $2,797 and credited to expense in 2021 of $460, respectively, compared to charges of $6,741 and $4,295 for the six months ended April 30, 2022 and 2021, respectively. The cumulative amount recorded in shareholders' equity at April 30, 2022 and 2021 was $13,756 and $4,132, respectively. As of April 30, 2022, there was $14,588 of unrecognized compensation cost related to performance share incentive awards. Deferred Compensation Our executive officers and other highly compensated employees may elect to defer up to 100% of their base pay and cash incentive compensation, and for executive officers, up to 90% of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended April 30, 2022 and 2021 was $18 and $29, respectively, compared to $36 and $58 for the six months ended April 30, 2022 and 2021, respectively. Deferred Directors’ Compensation Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared. The following table summarizes activity related to director deferred compensation share equivalent units during the six months ended April 30, 2022:
|  | Number of Shares |  | Weighted-Average Grant Date Fair Value
Outstanding at October 31, 2021 |  | 106 |  |  | $ | 68.11 |
Distributions |  | (7) |  |  | 48.01
Outstanding at April 30, 2022 |  | 99 |  |  | $ | 70.81 |
The amount charged to expense related to director deferred compensation for the three months ended April 30, 2022 and 2021 was $75 and $63 compared to $151 and $125 for the six months ended April 30, 2022 and 2021, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration